ISPOR EU 2022
6-9 November, 2022 | Vienna, Austria
We are excited to announce that we will be joining ISPOR EU 2022, the leading global conference for Health Economics and Outcomes Research. Our experts will join the event as speakers and presenters for multiple discussion and poster sessions.
Our speaker sessions:
Spotlight session
8th of November, 13:30 – 14:30
The Economics of Survival: A Discussion on the Role of Health Policy, Environmental Policy, & Economic Policy in Healthcare Decision Making
Our moderator
Richard Charter, Vice President MedTech Market Access – Europe & Asia Pacific
Forum session
8th of November, 11:45 – 12:45
HTA & Public Procurement of Medtech Solutions: Building a Bridge for Better Decision Making
Our panelist
Richard Charter, Vice President MedTech Market Access – Europe & Asia Pacific
Issue panel
9th of November, 10:00 – 11:00
External Control Arms, Is It the Way to Go?
Our moderator
Catia Proenca, Director in Market Access – RWE
Our speaker
Rajat Mukherjee, VP Adv. Statistics and Data Science
Podium session
7th of November, 16:45PM – 17:00PM (Part of Podium Session “Key Trends in HTA Policy: Present and Future”)
Potential Areas of Focus for the Future EU HTA Methodology: Discrepancies between EUnetHTA Vs National Evaluations
Our speaker
Nuria Rodriguez García, Director, Access and Pricing Europe
Our posters:
Poster: Project Orbis to Accelerate Patient Access to Innovative Cancer Therapies: A Narrative Review
Presenter: Beatriz Massó Authors: Ricci JF, Hurtado P, Demont E, Sathi C, Castañer A, Machuca P, Massó B
Poster: EU Joint Clinical Assessment Initiative: Process and Access Strategy Implications
Presenter: Celia Sathi Authors: Ricci JF, Hurtado P, Demont E, Sathi C, Castañer A, Machuca P, Massó B
Poster: Relationship between the Number of Approved Cancer Treatments and Unmet Need
Presenter: Oscar Dumoulin Authors: Dumoulin O, Bento G, Reinert M & Gulotta G
Poster: Impact of Publication of the French Commission for Economic and Public Health Evaluation (CEESP) Doctrine on the Conclusions of Its Economic Opinions
Presenters: Anne-Line Couillerot Author: Marine Meyer, Malika Belamri, Erwan Autin, Anne-Line Couillerot
Poster: HTA Assessment of Adaptive Trials for Oncology Drugs in Europe
Presenter: Oscar Dumoulin Authors: Bento G, Dumoulin O, Reinert M & Gulotta G
Poster: Best Practices for ECA design to optimize HTA acceptance
Presenter: Alexa Vidalis Authors: Catia Proenca, Oscar Dumoulin, Alexa Vidalis
Poster: Burden of disease in asthma, stratified by EOS levels in the UK
Presenter: Oscar Dumoulin Authors: Catia Proenca, Oscar Dumoulin, Aurelie Martinot, Pepi Hurtado, Mathieu Rose
Poster: Management of the post-surgery hospital care in France according to the type of surgery: a French claims database analysis
Presenter: Nicoleta Petrica Authors: Nicoleta Petrica, Mathieu Rose, Romain Finas
Poster: Impact of Publication of the French Commission for Economic and Public Health Evaluation (CEESP) Doctrine on the Conclusions of Its Economic Opinions
Presenter: Marine Meyer Authors: Marine Meyer, Malika Belamri, Erwan Autin, Anne-Line Couillerot
Poster: Are there specificities for assessing quality of life and utilities in rare diseases for economic evaluation in France: a case study of published CEESP opinions
Presenter: Sarah Sadeuk-Benabbas Authors: Sarah Sadeuk-Benabbas, Erwan Autin, Anne-Line Couillerot, Valérie Clément
Poster: Evolution of the Number of Metastatic Lung Cancer Patients before and during the COVID 19 Pandemic: A French National Hospital Database Analysis
Presenter: Nicoleta Petrica Authors: Batourou Sano, Nicoleta Petrica, Mathieu Rose
Poster: Current and Future Trends in P&R Decisions of Oncology and Onco-Hematology Drugs in Spain: A retrospective and forum discussion study
Presenter: Vázquez Manuel Authors: Vázquez Manuel, Castillo Chus, Bordoy Clara, Cruz Jessica, Manau Marc
Poster: The Catalan Health Service, An Example Where Patients Have Full Medicine Appraisal and Decision-Making Representation
Presenter: Chus Castillo Authors: Vázquez Manuel, Castillo Chus, Bordoy Clara, Cruz Jessica, Manau Marc
Poster: Impact of Independence and Transparency on Drug Availability and Time to Market: EU4 Qualitative and Quantitative Analysis of Pricing, Reimbursement, and Access Processes
Presenter: Castillo Chus Authors: Castillo Chus, Vázquez Manuel, Vico TaniaVidal-Barraquer EduardSubscribe to our newsletter for the latest news, events, and thought leadership